Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial

Douglas E. Jorenby, J. Taylor Hays, Nancy A. Rigotti, Salomon Azoulay, Eric J. Watsky, Kathryn E. Williams, Clare B. Billing, Jason Gong, Karen R. Reeves

Research output: Contribution to journal › Article › peer-review

1173 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences